ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 228 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $987,000 | +19.1% | 23,445 | +1.9% | 0.01% | 0.0% |
Q3 2019 | $829,000 | +146.0% | 23,018 | +83.3% | 0.01% | +200.0% |
Q2 2019 | $337,000 | -9.4% | 12,558 | -9.0% | 0.00% | -33.3% |
Q1 2019 | $372,000 | +65.3% | 13,807 | +5.4% | 0.00% | +50.0% |
Q4 2018 | $225,000 | -19.4% | 13,099 | -2.1% | 0.00% | 0.0% |
Q3 2018 | $279,000 | +92.4% | 13,380 | +99.0% | 0.00% | +100.0% |
Q2 2018 | $145,000 | 0.0% | 6,722 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $145,000 | -22.0% | 6,722 | +9.3% | 0.00% | -50.0% |
Q4 2017 | $186,000 | -24.7% | 6,149 | -5.5% | 0.00% | -33.3% |
Q3 2017 | $247,000 | +112.9% | 6,509 | +56.8% | 0.00% | +200.0% |
Q2 2017 | $116,000 | +31.8% | 4,151 | +62.1% | 0.00% | 0.0% |
Q1 2017 | $88,000 | +49.2% | 2,561 | +28.0% | 0.00% | 0.0% |
Q4 2016 | $59,000 | 0.0% | 2,000 | +6.6% | 0.00% | 0.0% |
Q3 2016 | $59,000 | +63.9% | 1,877 | +64.9% | 0.00% | 0.0% |
Q2 2016 | $36,000 | +33.3% | 1,138 | +15.1% | 0.00% | – |
Q1 2016 | $27,000 | -32.5% | 989 | -12.6% | 0.00% | -100.0% |
Q4 2015 | $40,000 | +5.3% | 1,131 | -2.7% | 0.00% | 0.0% |
Q3 2015 | $38,000 | -7.3% | 1,162 | +19.2% | 0.00% | 0.0% |
Q2 2015 | $41,000 | +241.7% | 975 | +156.6% | 0.00% | – |
Q1 2015 | $12,000 | +200.0% | 380 | +230.4% | 0.00% | – |
Q4 2014 | $4,000 | +33.3% | 115 | 0.0% | 0.00% | – |
Q3 2014 | $3,000 | 0.0% | 115 | 0.0% | 0.00% | – |
Q2 2014 | $3,000 | +200.0% | 115 | +360.0% | 0.00% | – |
Q1 2014 | $1,000 | -93.8% | 25 | -96.1% | 0.00% | – |
Q4 2013 | $16,000 | +1500.0% | 645 | +2480.0% | 0.00% | – |
Q3 2013 | $1,000 | – | 25 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |